Intravenous thrombolytic therapy for acute ischemic stroke - Weighing the risks and benefits of tissue plasminogen activator

被引：5
|
作者：
Koller, RL
Anderson, DC
机构：
[1] Koller Clin Neurol, Bend, OR 97701 USA
[2] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA
来源：
POSTGRADUATE MEDICINE | 1998年 / 103卷 / 04期
关键词：
D O I：
10.3810/pgm.1998.04.457
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The use of intravenous tPA within 3 hours after acute ischemic stroke has been proved to increase the number of good outcomes. However, tPA is a toxic therapy that carries a substantial risk of intracerebral hemorrhage. To decrease the risk, tPA use must be restricted to a carefully selected patient population. Treatment must be administered in an intensive care setting and directed by physicians with expertise in diagnosing and managing stroke.
引用
收藏
页码：221 / +
页数：7
相关论文
共 50 条
  • [1] Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator
    Xian, Ying
    Federspiel, Jerome J.
    Grau-Sepulveda, Maria
    Hernandez, Adrian F.
    Schwamm, Lee H.
    Bhatt, Deepak L.
    Smith, Eric E.
    Reeves, Mathew J.
    Thomas, Laine
    Webb, Laura
    Bettger, Janet Prvu
    Laskowitz, Daniel T.
    Fonarow, Gregg C.
    Peterson, Eric D.
    [J]. JAMA NEUROLOGY, 2016, 73 (01) : 50 - 59
  • [2] Physician knowledge of the benefits, risks, and contraindications of tissue plasminogen activator for acute ischemic stroke
    Merino, JG
    Silver, B
    Wong, E
    Demaerschalk, B
    Tamayo, A
    Hachinski, V
    [J]. STROKE, 2001, 32 (09) : 2208 - 2209
  • [3] Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry
    Matsuo, Ryu
    Kamouchi, Masahiro
    Ago, Tetsuro
    Hata, Jun
    Shono, Yuji
    Kuroda, Junya
    Wakisaka, Yoshinobu
    Sugimori, Hiroshi
    Kitazono, Takanari
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2014, 14 (04) : 954 - 959
  • [4] Usefulness of three phase spiral CT in thrombolytic therapy with intravenous recombinant tissue plasminogen activator for acute ischemic stroke
    Lee, KH
    Cho, SJ
    Na, DK
    Chung, CS
    Byun, HS
    Song, HJ
    Lee, SJ
    Lee, TG
    Jin, IS
    [J]. NEUROLOGY, 1999, 52 (06) : A454 - A455
  • [5] Utilization of intravenous tissue plasminogen activator for acute ischemic stroke
    Katzan, IL
    Hammer, MD
    Hixson, ED
    Furlan, AJ
    Abou-Chebl, A
    Nadzam, DM
    [J]. ARCHIVES OF NEUROLOGY, 2004, 61 (03) : 346 - 350
  • [6] Thrombolytic therapy for acute ischemic stroke: risks vs benefits
    Lindbloom, EJ
    [J]. JOURNAL OF FAMILY PRACTICE, 2003, 52 (10): : 757 - +
  • [7] Tissue Plasminogen Activator Thrombolytic Therapy for Acute Ischemic Stroke in 4 Hospital Groups in Japan
    Kono, Syoichiro
    Deguchi, Kentaro
    Morimoto, Nobutoshi
    Kurata, Tomoko
    Deguchi, Shoko
    Yamashita, Tohru
    Ikeda, Yoshio
    Matsuura, Tohru
    Narai, Hisashi
    Omori, Nobuhiko
    Manabe, Yasuhiro
    Yunoki, Taijyun
    Takao, Yoshiki
    Kawata, Sanami
    Kashihara, Kenichi
    Abe, Koji
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (03): : 190 - 196
  • [8] Sonothrombolysis: An effective adjunct to intravenous tissue plasminogen activator therapy in acute ischemic stroke
    Miyachi, Shigeru
    [J]. NEUROLOGY INDIA, 2017, 65 (01) : 20 - 21
  • [9] THROMBOLYTIC THERAPY IN ACUTE MI - WEIGHING THE RISKS AND BENEFITS
    RO, KG
    ANDERSON, HV
    [J]. POSTGRADUATE MEDICINE, 1990, 88 (08) : 79 - +
  • [10] Safety and efficacy of intravenous tissue plasminogen activator in acute ischemic stroke
    Rajapa, S.
    Sivakumar, S.
    Arjundas, D.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 133 - 133
12345